Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Farinotti

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Pathologie-Biologie|May 1, 1992
[Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection]V Le Gros, R Farinotti, N Brion, et al.
Therapie|January 1, 1986
[Topical digestive drugs with a clay base. Influence on the absorption of cimetidine]G Fredj, R Farinotti, C Salvadori, et al.
Chirality|June 16, 1999
Binding of chlorpheniramine enantiomers to human plasma proteinsB T Hiep, F Gimenez, V U Khanh, et al.
Chirality|April 3, 2001
Intestinal absorption and metabolism of chlorpheniramine enantiomers in ratB T Hiep, C Fernandez, M Tod, et al.
Journal of Hepatology|March 1, 1997
Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosisP Sogni, A Hadengue, R Moreau, et al.
Placenta|September 17, 2005
Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected womenM Camus, C Deloménie, N Didier, et al.
Chirality|July 18, 2000
Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramineT H Bui, C Fernandez, K Vu, et al.
Biochemical Pharmacology|May 12, 2009
Disposition of everolimus in mdr1a-/1b- mice and after a pre-treatment of lapatinib in Swiss miceC Chu, C Abbara, M S Noël-Hudson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 2, 2015
Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR bindingC Chu, M S Noël-Hudson, J Bénard, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2000
Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavirX Duval, V Le Moing, C Longuet, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Pathologie-Biologie|May 1, 1992
[Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection]V Le Gros, R Farinotti, N Brion, et al.
Therapie|January 1, 1986
[Topical digestive drugs with a clay base. Influence on the absorption of cimetidine]G Fredj, R Farinotti, C Salvadori, et al.
Chirality|June 16, 1999
Binding of chlorpheniramine enantiomers to human plasma proteinsB T Hiep, F Gimenez, V U Khanh, et al.
Chirality|April 3, 2001
Intestinal absorption and metabolism of chlorpheniramine enantiomers in ratB T Hiep, C Fernandez, M Tod, et al.
Journal of Hepatology|March 1, 1997
Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosisP Sogni, A Hadengue, R Moreau, et al.
Placenta|September 17, 2005
Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected womenM Camus, C Deloménie, N Didier, et al.
Chirality|July 18, 2000
Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramineT H Bui, C Fernandez, K Vu, et al.
Biochemical Pharmacology|May 12, 2009
Disposition of everolimus in mdr1a-/1b- mice and after a pre-treatment of lapatinib in Swiss miceC Chu, C Abbara, M S Noël-Hudson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 2, 2015
Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR bindingC Chu, M S Noël-Hudson, J Bénard, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2000
Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavirX Duval, V Le Moing, C Longuet, et al.
Pageof 19